Meloxicam vs Avanafil: side-by-side comparison
Meloxicam (NSAID (preferential COX-2 inhibitor)) and Avanafil (Phosphodiesterase type 5 (PDE5) inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Meloxicam | Avanafil |
|---|---|---|
| Therapeutic class | NSAID (preferential COX-2 inhibitor) | Phosphodiesterase type 5 (PDE5) inhibitor |
| CAS | 71125-38-7 | 330784-47-9 |
| ATC | M01AC06 | G04BE10 |
| Molecular weight | 351.40 g/mol | 483.95 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Meloxicam and Avanafil share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Meloxicam acts by a different mechanism than Avanafil, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Meloxicam: Le méloxicam inhibe les cyclo-oxygénases avec une préférence pour la COX-2 aux faibles doses thérapeutiques. Avanafil: L'avanafil inhibe sélectivement la phosphodiestérase de type 5 dans le corps caverneux, ce qui augmente le GMP cyclique et amplifie la vasodilatation médiée par le monoxyde d'azote en réponse à la stimulation sexuelle.
Indications compared
Meloxicam: Le méloxicam est autorisé chez l'adulte dans le traitement symptomatique de l'arthrose, de la polyarthrite rhumatoïde et de la spondylarthrite ankylosante. Avanafil: L'avanafil est autorisé dans la dysfonction érectile chez l'homme adulte.
Safety profile
Meloxicam: Les effets indésirables fréquents comprennent troubles digestifs, œdèmes périphériques, hypertension et céphalées. Avanafil: Les effets indésirables les plus fréquents sont les céphalées, les bouffées vasomotrices, la congestion nasale et les douleurs dorsales — typiques de la classe des inhibiteurs de la PDE5, mais généralement moins fréquent…
Questions fréquentes
Is Meloxicam better than Avanafil? ▾
Meloxicam and Avanafil are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Meloxicam and Avanafil be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Meloxicam
Products with Avanafil
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.